While it needs to be considered that our observations derive from a retrospective analysis of data obtained at a single center, these results nevertheless indicate that in contrast to epithelial tumors, HER2/neu expression does not constitute a prognostic marker for disease course in ALL. This evidence concerns the gene ERBB2 and acute lymphoblastic leukemia.